Found 73 bookmarks
Custom sorting
SARS-CoV-2 Orf6 Triggers MTCH1-Dependent Mitochondrial Dysfunction and Necroptosis in Human Neurons | Research Square
SARS-CoV-2 Orf6 Triggers MTCH1-Dependent Mitochondrial Dysfunction and Necroptosis in Human Neurons | Research Square

A new preprint study shows that the SARS-CoV-2 protein ORF6 directly kills human neurons. Not by accident, but through necroptosis - a kind of cell death where neurons burst and fuel inflammation. This may underlie the long-term brain symptoms of Long COVID.

·researchsquare.com·
SARS-CoV-2 Orf6 Triggers MTCH1-Dependent Mitochondrial Dysfunction and Necroptosis in Human Neurons | Research Square
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - PubMed
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - PubMed
COVID-19 convalescents had a greater likelihood of developing Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and stroke 6 months after infection, as compared to those affected by influenza or any other respiratory infections.
·pubmed.ncbi.nlm.nih.gov·
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records - PubMed
An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson’s Disease Protein Alpha-Synuclein
An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson’s Disease Protein Alpha-Synuclein
“Overall, our findings raise compelling questions about the potential role of SARS-CoV-2 infection in accelerating or triggering neurodegenerative diseases linked to protein amyloidosis”
·pubs.acs.org·
An Amyloidogenic Fragment of the Spike Protein from SARS-CoV-2 Virus Stimulates the Aggregation and Toxicity of Parkinson’s Disease Protein Alpha-Synuclein
A Peripheral Neuron-to-Microglia Signaling Axis Connecting Transient Viral Infection to Persistent Neuroinflammatory States | Research Square
A Peripheral Neuron-to-Microglia Signaling Axis Connecting Transient Viral Infection to Persistent Neuroinflammatory States | Research Square

How does a transient viral infection like COVID lead to long lasting neurologic symptoms?

In humans and in animal models, SARS-CoV-2 can damage peripheral sensory nerves in the nose, leaving behind debris that can then trigger inflammation in brain microglia for weeks to months after infection, which can then lead to post-viral neurological symptoms like cognitive dysfunction (brain fog).

The peripheral neuron-to-microglia axis offers a potential explanation for persistent inflammation seen in conditions like Long COVID and ME/CFS.

·researchsquare.com·
A Peripheral Neuron-to-Microglia Signaling Axis Connecting Transient Viral Infection to Persistent Neuroinflammatory States | Research Square
Neuropsychiatric Risks Linked to COVID-19 Revealed
Neuropsychiatric Risks Linked to COVID-19 Revealed

New Nature study shows SARS2 significantly elevates the risk of neuropsychiatric conditions including anxiety, mood disorders, cognitive impairment and psychotic disorders for up to 6 months.

“Alarmingly, even individuals with mild or asymptomatic infections face elevated risk.”

·bioengineer.org·
Neuropsychiatric Risks Linked to COVID-19 Revealed
Thread by @JamesThrot on Thread Reader App
Thread by @JamesThrot on Thread Reader App

“Let’s talk about COVID, brain damage & society.

Specifically, what happens when a neurotropic virus repeatedly infects the population, targeting the frontal lobe & almost nobody talks about the consequences?

This thread is for the skeptics.

I’m a neurologist, stay with me 🧵”

Let’s talk about COVID, brain damage & society. Specifically, what happens when a neurotropic virus repeatedly infects the population, targeting the frontal lobe & almost nobody talks about the consequences? This thread is for the skeptics. I’m a neurologist, stay with me 🧵
·threadreaderapp.com·
Thread by @JamesThrot on Thread Reader App
Human challenge study reveals lasting cognitive decline after mild COVID-19
Human challenge study reveals lasting cognitive decline after mild COVID-19

“significant memory and executive function decline lasting up to a year, despite no reported subjective symptoms, prompting new questions about the virus’s long-term cognitive effects.”

Unvaccinated volunteers who contracted COVID-19 in a human challenge study showed
·news-medical.net·
Human challenge study reveals lasting cognitive decline after mild COVID-19
Thread by @ZdenekVrozina on Thread Reader App
Thread by @ZdenekVrozina on Thread Reader App

“Long COVID can injure the brain - and persistent autoimmunity could be a major driver. A study links persistent AT1 receptor autoantibodies (AT1-AA) with neuroaxonal injury and cognitive symptoms. Here’s what it means🧵”

Long COVID can injure the brain - and persistent autoimmunity could be a major driver. A study links persistent AT1 receptor autoantibodies (AT1-AA) with neuroaxonal injury and cognitive symptoms. Here’s what it means🧵
·threadreaderapp.com·
Thread by @ZdenekVrozina on Thread Reader App
Frontiers | Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients
Frontiers | Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients
“Dysregulation of autoimmune responses and the presence of autoantibodies (AA), particularly those related to the renin-angiotensin system (RAS), have been implicated in the acute phase of COVID-19, and persistent dysregulation of brain RAS by RAS-related autoantibodies may also contribute to neurological symptoms of post-COVID.”
Dysregulation of autoimmune responses and the presence of autoantibodies (AA), particularly those related to the renin-angiotensin system (RAS), have been implicated in the acute phase of COVID-19, and persistent dysregulation of brain RAS by RAS-related autoantibodies may also contribute to neurological symptoms of post-COVID.
·frontiersin.org·
Frontiers | Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection

“COVID-19 survivors were at higher adjusted risk of mortality, major adverse cardiovascular events, fatigue, sleep disturbance, and dyspnea. • COVID-19 may be a risk factor for onset of symptoms and adverse events in patients with neurological conditions”

COVID-19 survivors were at higher adjusted risk of mortality, major adverse cardiovascular events, fatigue, sleep disturbance, and dyspnea.•COVID-19 may be a risk factor for onset of symptoms and adverse events in patients with neurological conditions
·sciencedirect.com·
Long-term outcomes of patients with a pre-existing neurological condition after SARS-CoV-2 infection
Dad, 41, Diagnosed with Alzheimer's: 'You Feel Guilty That You're Doing That to the Kids'
Dad, 41, Diagnosed with Alzheimer's: 'You Feel Guilty That You're Doing That to the Kids'

“Dad, 41, Diagnosed with Alzheimer's: 'You Feel Guilty That You're Doing That to the Kids' Fraser is sharing his symptoms — and what he’s learned about the disease — on his YouTube channel”

Dad, 41, Diagnosed with Alzheimer's: 'You Feel Guilty That You're Doing That to the Kids' Fraser is sharing his symptoms — and what he’s learned about the disease — on his YouTube channel
·people.com·
Dad, 41, Diagnosed with Alzheimer's: 'You Feel Guilty That You're Doing That to the Kids'
Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients - BMC Neurology
Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients - BMC Neurology
Egyptian researchers analyzed data from over 4 million people and found that nearly 1 in 3 COVID-19 survivors face long-term cognitive or memory problems, while 43% experience persistent fatigue, revealing a major mental health burden from long COVID.
·bmcneurol.biomedcentral.com·
Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in over 4 million patients - BMC Neurology
Unusual Post–COVID-19 Presentation With Tetraventricular Hydrocephalus | Neurology Clinical Practice
Unusual Post–COVID-19 Presentation With Tetraventricular Hydrocephalus | Neurology Clinical Practice
“COVID-19 infection is suggested as one of the causes for hydrocephalus (HCP) of unknown etiology. “
COVID-19 infection is suggested as one of the causes for hydrocephalus (HCP) of unknown etiology.
·neurology.org·
Unusual Post–COVID-19 Presentation With Tetraventricular Hydrocephalus | Neurology Clinical Practice
Multimodal MRI analysis of COVID-19 effects on pediatric brain
Multimodal MRI analysis of COVID-19 effects on pediatric brain

Even mild Covid changes children’s brains.

“We speculate that viral-triggered neuroinflammation and immune response contribute to neurotoxic damage in brain regions involved in cognitive processing, ultimately resulting in alterations in cortical morphology and glymphatic function.”

We speculate that viral-triggered neuroinflammation and immune response contribute to neurotoxic damage in brain regions involved in cognitive processing, ultimately resulting in alterations in cortical morphology and glymphatic function.
·nature.com·
Multimodal MRI analysis of COVID-19 effects on pediatric brain
newsGP - How COVID-19 leaves its mark on the brain
newsGP - How COVID-19 leaves its mark on the brain
“Mounting research shows the disease can lead to an array of problems, including significant drops in IQ scores, writes Dr Ziyad Al-Aly.”
Mounting research shows the disease can lead to an array of problems, including significant drops in IQ scores, writes Dr Ziyad Al-Aly.
·www1.racgp.org.au·
newsGP - How COVID-19 leaves its mark on the brain
Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics
Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics
“Outpatients with post-COVID-19 conditions exhibited extensive hypometabolic right fronto-temporal clusters. Patients with more numerous symptoms during the initial phase and with a longer duration of symptoms were at higher risk of persistent brain involvement.”
Outpatients with post-COVID-19 conditions exhibited extensive hypometabolic right fronto-temporal clusters. Patients with more numerous symptoms during the initial phase and with a longer duration of symptoms were at higher risk of persistent brain involvement.
·link.springer.com·
Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics